Loading
Biomaxima S.A. Stock: price and insider trades · Poland
PL·Mcap PLN 41.8M
1 insider bought €86k of shares over the last 90 days, the latest by Asakura sp. z o.o., filed 13 Aug 2026.
Biomaxima S.A.: what insiders have been doing
Only a handful of insider records exist for Biomaxima S.A., the last one from 13 August 2026, too few to describe a trend. Source: insider filings from KNF. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€86,027
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAsakura sp. z o.o.1 buy
Since the insiders bought
- -1.0%Entry PLN 10.28 · Close at T+30 PLN 10.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,732 of 26,289 companies
45.4
score / 100
Value50
Quality41
FCF yld5.7%
Earn yld0.3%
EV/EBITDA11.0x
ROE1.7%
Gross mgn44%
Net mgn0.2%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
PLN 9.97
Analyst consensus
Income statement
RevenuePLN 60.9M
Gross profitPLN 26.7M44% margin
EBITDAPLN 5.1M8% margin
Net incomePLN 105k1.3% margin
Valuation
PER (trailing)47.5x
P/Book0.8x
Beta0.31
Balance sheet & cash
Market capPLN 41.8M
Total debtPLN 14.5M
Free Cash FlowPLN 2.4M
Debt / Equity28%
Profitability & ownership
ROE1.7%
ROA1.5%
% insiders34.4%
% institutions0.1%
Last declaration on 13 August 2026
Declarations1 total
35,292 shares@ PLN 10.500.90% mcap100.0% of flowShareWSEKNF:node/734455
Canonical exit: 10 Nov 2026 (T+90)
1 of 1 declaration
About Biomaxima S.A.
Biomaxima S.A. is a Polish company specializing in the development and production of medical diagnostic reagents. It primarily operates on the Warsaw stock market.